UG3 Pilot Clinical Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Lung Cancer
Interventions
OTHER

Repeated Text Messages (TM+)

The text message notifies patients that they may be eligible for LCS and provides the patient with a connection to an registered nurse (RN) for LCS eligibility assessment and Shared Decision-Making (SDM) discussion. Response options include YES (to request that the HUB RN call the patient) or STOP (to opt out of any further messages).

OTHER

Conversational Agent (CA)

The CA is designed to address specific hesitancy factors and barriers to Lung Cancer Screening (LCS). The CA uses a rule-based approach. CAs use a predefined conversation script with a fixed set of possible questions and responses to educate patients regarding the importance of LCS and engage them to be connected with RN for eligibility assessment and SDM.

OTHER

Educational Video

The educational video provides patients with information and answers commonly asked questions about LCS.

OTHER

Proactive Patient Navigation (PPN)

Proactive patient navigation enables trained navigators to actively identify and reach out to patients who may need assistance completing LCS, rather than waiting for patients to seek help on their own.

OTHER

Reactive Patient Navigation (RPN)

Reactive patient navigation makes trained navigators available to those who seek assistance in completing LCS.

Trial Locations (1)

84112

Huntsman Cancer Institute/ University of Utah, Salt Lake City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Utah

OTHER